L-DOPA/carbidopa for nocturnal movement disorders in uremia

Sleep

Volumn 19, Issue 3, 1996, Pages 214-218

  Walker, Shannon Louise ^a   Fine, Adrian ^a   Kryger, Meir H ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

Author keywords

L DOPA; Nocturnal leg movements; Periodic limb movements in sleep; Restless legs syndrome; Sleep; Uremia

Indexed keywords

CARBIDOPA; CARBIDOPA PLUS LEVODOPA; LEVODOPA; PLACEBO;

ADULT; AGED; AROUSAL; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; LEG MOVEMENT; MALE; MOTOR DYSFUNCTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; SLOW WAVE SLEEP; UREMIA;

AGED; CLINICAL PROTOCOLS; CROSS-OVER STUDIES; DOPAMINE AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LEVODOPA; MALE; PLACEBOS; POLYSOMNOGRAPHY; RESTLESS LEGS SYNDROME; SLEEP; SLEEP STAGES; UREMIA;

EID: 0029872419     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Holley JL, Nespar S, Rault R. A comparison of reported sleep disorders in patients on chronic hemodialysis and continuous peritoneal dialysis. Am J Kidney Dis 1992;XIX:156-61.
2. Montplaisir J, Lapierre O, Warnes H, Pelletier G. The treatment of the restless leg syndrome with or without periodic leg movements in sleep. Sleep 1992;15:391-5
3. Von Scheele C, Kempi V. Long-term effect of dopaminergic drugs in restless legs (a 2-year follow-up). Arch Neurol 1990;47: 1223-4.
4. Becker PM, Jamieson AO, Brown WD. Dopaminergic agents in restless legs syndrome and periodic limb movements of sleep: response and complications of extended treatment in 49 cases. Sleep 1993;16:713-6.
5. Brodeur C, Montplaisir J, Godbout R, Marinier R. Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study. Neurology 1988;38:1845-8.
6. Sandyk R, Bernick C, Lee SM, Stern LZ, Iacono RP, Bamford CR. L-dopa in uremic patients with the restless legs syndrome. Int J Neurosci 1987;35:233-5.
7. Diagnostic Classification Steering Committee, Thorpy MJ, chairman. International classification of sleep disorders: diagnostic and coding manual. Rochester, MN: American Sleep Disorders Association, 1990:69-70.
8. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles: Brain Information Service, 1968.
9. The Atlas Task Force. Recording and scoring leg movements. Sleep 1993;16:748-59.
10. Trenkwalder C, Stiasny K, Pollmächer Th, et al. L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial. Sleep 1995;18:681-8.
11. Bliwise DL, Carskadon MA, Dement WC. Nightly variation of periodic leg movements in sleep in middle aged and elderly individuals. Arch Gerontol Geriatr 1988;7:273-9.
12. Mosko SS, Dickel MJ, Ashurst J. Night-to-night variability in sleep apnea and sleep-related periodic leg movements in the elderly. Sleep 1988;11:340-8.